crc press - E-Lib FK UWKS

50 Cell-Penetrating Peptides: Processes and Applications
49. Chen, Y.N. et al., Selective killing of transformed cells by cyclin/cyclin-dependent
kinase 2 antagonists, Proc. Natl. Acad. Sci. USA, 96, 4325, 1999.
50. Sharma, S.K. et al., Identification of E2F-1/Cyclin A antagonists, Bioorg. Med. Chem.
Lett., 11, 2449, 2001.
51. Lin, X. et al., SSeCKS, a major protein kinase C substrate with tumor suppressor
activity, regulates G(1) — >S progression by controlling the expression and cellular
compartmentalization of cyclin D, Mol. Cell Biol., 20, 7259, 2000.
52. Herbert, T.P. et al., Rapid induction of apoptosis mediated by peptides that bind
initiation factor eIF4E, Curr. Biol., 10, 793, 2000.
53. Hutton, F.G. et al., Consequences of disruption of the interaction between p53 and
the larger adenovirus early region 1B protein in adenovirus E1 transformed human
cells, Oncogene, 19, 452, 2000.
54. Mittelman, J.M. and Gudkov, A.V., Generation of p53 suppressor peptide from the
fragment of p53 protein, Somat. Cell Mol. Genet., 25, 115, 1999.
55. Komarov, P.G. et al., A chemical inhibitor of p53 that protects mice from the side
effects of cancer therapy, Science, 285, 1733, 1999.
56. Giorello, L., et al., Inhibition of cancer cell growth and c-Myc transcriptional activity
by a c-Myc helix 1-type peptide fused to an internalization sequence, Cancer Res.,
58, 3654, 1998.
57. Pescarolo, M.P. et al., A retro-inverso peptide homologous to helix 1 of c-Myc is a
potent and specific inhibitor of proliferation in different cellular systems, FASEB J.,
15, 31, 2001.
58. Liu, G.S. et al., Protein kinase C-epsilon is responsible for the protection of preconditioning
in rabbit cardiomyocytes, J. Mol. Cell Cardiol., 31, 1937, 1999.
59. Dostmann, W.R. et al., Highly specific, membrane-permeant peptide blockers of
cGMP-dependent protein kinase Ialpha inhibit NO-induced cerebral dilation, Proc.
Natl. Acad. Sci. USA, 97, 14772, 2000.
60. Hall, H. et al., Inhibition of FGF-stimulated phosphatidylinositol hydrolysis and
neurite outgrowth by a cell-membrane permeable phosphopeptide, Curr. Biol., 6, 580,
1996.
61. Peck, D. and Isacke, C.M., Hyaluronan-dependent cell migration can be blocked by
a CD44 cytoplasmic domain peptide containing a phosphoserine at position 325, J.
Cell Sci., 111, 1595, 1998.
62. Calvet, S. et al., Identification of a signaling pathway activated specifically in the
somatodendritic compartment by a heparan sulfate that regulates dendrite growth, J.
Neurosci., 18, 9751, 1998.
63. Bardelli, A. et al., A peptide representing the carboxyl-terminal tail of the met receptor
inhibits kinase activity and invasive growth, J. Biol. Chem., 274, 29274, 1999.
64. Nielsen, P.E., Peptide nucleic acids as therapeutic agents, Curr. Opin. Struct. Biol.,
9, 353, 1999.
65. Villa, R. et al., Inhibition of telomerase activity by a cell-penetrating peptide nucleic
acid construct in human melanoma cells, FEBS Lett., 473, 241, 2000.
66. Simmons, C.G. et al., Synthesis and membrane permeability of PNA-peptide conjugate,
Bioorg. Med. Chem. Lett., 7, 3001, 1997.
67. Pooga, M. et al., Cell penetrating PNA constructs regulate galanin receptor levels and
modify pain transmission in vivo, Nat. Biotechnol., 16, 857, 1998.
68. Maizel, A. et al., A short region of its homeodomain is necessary for engrailed nuclear
export and secretion, Development, 126, 3183, 1999.
69. Joliot, A. et al., Identification of a signal sequence necessary for the unconventional
secretion of engrailed homeoprotein, Curr. Biol., 8, 856, 1998.